• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

在大流行期间利用公众的恐惧和焦虑：销售未经证实和未经许可的“干细胞治疗”COVID-19 的企业。

Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19.

机构信息

Center for Bioethics, School of Public Health, and College of Pharmacy, University of Minnesota, 410 Church Street SE, N520, Minneapolis, MN 55455, USA.

出版信息

Cell Stem Cell. 2020 Jun 4;26(6):806-810. doi: 10.1016/j.stem.2020.05.003. Epub 2020 May 7.

DOI:10.1016/j.stem.2020.05.003
PMID:32464095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7203029/
Abstract

In the midst of a global public health emergency, some businesses are taking advantage of widespread fears by marketing purported stem cell treatments for COVID-19. Such businesses target prospective clients with misleading claims, expose patients to potentially risky stem cell-based products, and undermine efforts to develop evidence-based treatments for COVID-19.

摘要

在全球公共卫生紧急事件中，一些企业利用广泛的恐惧心理，推销所谓的用于治疗 COVID-19 的干细胞疗法。这些企业通过误导性的宣传来吸引潜在客户，使患者面临潜在的风险干细胞产品，并破坏开发基于证据的 COVID-19 治疗方法的努力。

相似文献

1
Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19.在大流行期间利用公众的恐惧和焦虑：销售未经证实和未经许可的“干细胞治疗”COVID-19 的企业。
Cell Stem Cell. 2020 Jun 4;26(6):806-810. doi: 10.1016/j.stem.2020.05.003. Epub 2020 May 7.
2
Fear, information and control during a pandemic.大流行期间的恐惧、信息与管控
Tidsskr Nor Laegeforen. 2020 Jun 22;140(10). doi: 10.4045/tidsskr.20.0346. Print 2020 Jun 30.
3
Pertinent roles of African higher institutions in the COVID-19 pandemic response: The University of Ilorin, Ilorin, Nigeria; An African Model.非洲高等院校在应对新冠疫情中的相关作用：尼日利亚伊洛林大学；一个非洲范例。
Int J Health Plann Manage. 2020 Sep;35(5):1257-1259. doi: 10.1002/hpm.2984. Epub 2020 May 25.
4
Fear and Understanding in the Time of COVID-19.新冠疫情时期的恐惧与理解
Pediatr Neurol. 2020 Oct;111:37-38. doi: 10.1016/j.pediatrneurol.2020.06.015. Epub 2020 Jun 26.
5
Suicide research and prevention during and after the COVID-19 pandemic.2019冠状病毒病大流行期间及之后的自杀研究与预防
Acta Psychiatr Scand. 2020 Nov;142(5):353-354. doi: 10.1111/acps.13248.
6
Challenges and Opportunities Created by the COVID-19 Pandemic.新冠疫情带来的挑战与机遇
J Nutr Educ Behav. 2020 Jul;52(7):669-670. doi: 10.1016/j.jneb.2020.05.005. Epub 2020 May 21.
7
Lived Experiences during the COVID-19 Pandemic.2019冠状病毒病大流行期间的生活经历
Issues Ment Health Nurs. 2020 Aug;41(8):661. doi: 10.1080/01612840.2020.1773738.
8
Pandemics, panic and prevention: Stages in the life of COVID-19 pandemic.大流行、恐慌与预防：新冠疫情历程中的阶段
Int J Soc Psychiatry. 2020 Dec;66(8):733-734. doi: 10.1177/0020764020924449. Epub 2020 May 2.
9
Alone Together in Our Fear: Perspectives From the Early Days of Lockdown Due to COVID-19.在恐惧中独自相伴：来自新冠疫情封锁初期的视角
J Nerv Ment Dis. 2020 Jun;208(6):441-442. doi: 10.1097/NMD.0000000000001202.
10
The next pandemic: COVID-19 mental health pandemic.下一场大流行：新冠疫情引发的心理健康大流行。
Perspect Psychiatr Care. 2020 Jul;56(3):485. doi: 10.1111/ppc.12571.

引用本文的文献

1
Clinical use of autologous cell-based therapies in an evolving regulatory landscape: A survey of patient experiences and perceptions.在不断发展的监管环境下，自体细胞疗法的临床应用：一项关于患者体验和看法的调查。
F1000Res. 2024 Aug 27;12:1165. doi: 10.12688/f1000research.141002.2. eCollection 2023.
2
The evolution and ongoing challenge of unproven cell-based interventions.未经证实的基于细胞的干预措施的演变和持续挑战。
Stem Cells Transl Med. 2024 Sep 10;13(9):851-858. doi: 10.1093/stcltm/szae050.
3
Businesses marketing purported stem cell treatments and exosome therapies for COVID-19: An analysis of direct-to-consumer online advertising claims.针对 COVID-19 的所谓干细胞治疗和外泌体疗法的商业营销：对直接面向消费者的在线广告声明的分析。
Stem Cell Reports. 2023 Nov 14;18(11):2010-2015. doi: 10.1016/j.stemcr.2023.09.015. Epub 2023 Oct 26.
4
The Art of Stem Cell-Based Therapy.基于干细胞的治疗艺术。
Adv Exp Med Biol. 2023;1420:1-12. doi: 10.1007/978-3-031-30040-0_1.
5
The Early Detection of Fraudulent COVID-19 Products From Twitter Chatter: Data Set and Baseline Approach Using Anomaly Detection.从推特聊天中早期检测新冠欺诈产品：使用异常检测的数据集和基线方法
JMIR Infodemiology. 2023 Mar 14;3:e43694. doi: 10.2196/43694. eCollection 2023.
6
The Direct to Consumer Stem Cell Market and the Role of Primary Care Providers in Correcting Misinformation.直接面向消费者的干细胞市场和初级保健提供者在纠正错误信息方面的作用。
J Prim Care Community Health. 2022 Jan-Dec;13:21501319221121460. doi: 10.1177/21501319221121460.
7
Developing a Paradigm Model for Resilience of Rural Entrepreneurial Businesses in Dealing With the COVID-19 Crisis; Application of Grounded Theory in Western of Iran.发展农村创业企业应对 COVID-19 危机的韧性范式模型；扎根理论在伊朗西部的应用。
Front Public Health. 2022 Feb 25;10:833909. doi: 10.3389/fpubh.2022.833909. eCollection 2022.
8
Online seminars as an information source for direct-to-consumer stem cell therapy.在线研讨会作为面向消费者的干细胞治疗的信息来源。
Regen Med. 2022 Feb;17(2):81-90. doi: 10.2217/rme-2021-0070. Epub 2021 Dec 24.
9
RESTORE Survey on the Public Perception of Advanced Therapies and ATMPs in Europe-Why the European Union Should Invest More!欧洲关于公众对先进疗法和高级治疗用药品认知的恢复调查——为何欧盟应加大投资！
Front Med (Lausanne). 2021 Oct 26;8:739987. doi: 10.3389/fmed.2021.739987. eCollection 2021.
10
Generation and Effect Testing of a SARS-CoV-2 RBD-Targeted Polyclonal Therapeutic Antibody Based on a 2-D Airway Organoid Screening System.基于二维气道类器官筛选系统的 SARS-CoV-2 RBD 靶向多克隆治疗性抗体的产生和效果测试。
Front Immunol. 2021 Oct 18;12:689065. doi: 10.3389/fimmu.2021.689065. eCollection 2021.

本文引用的文献

1
Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential.基于细胞的 2019 冠状病毒病治疗方法：恰当的临床研究至关重要。
Cytotherapy. 2020 Nov;22(11):602-605. doi: 10.1016/j.jcyt.2020.04.089. Epub 2020 Apr 17.
2
Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: A case report.人脐带间充质干细胞治疗危重症新型冠状病毒肺炎患者临床缓解一例报告
Medicine (Baltimore). 2020 Jul 31;99(31):e21429. doi: 10.1097/MD.0000000000021429.
3
Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19.细胞疗法治疗呼吸道病毒感染的现状：在 COVID-19 中的适用性。
Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.00858-2020. Print 2020 Jun.
4
Transplantation of ACE2 Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia.血管紧张素转换酶2间充质干细胞移植改善新型冠状病毒肺炎患者的预后。
Aging Dis. 2020 Mar 9;11(2):216-228. doi: 10.14336/AD.2020.0228. eCollection 2020 Apr.
5
Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.扩充脐带间充质干细胞（UC-MSCs）作为治疗危重症 COVID-19 患者的一种治疗策略：同情用药的理由。
Pain Physician. 2020 Mar;23(2):E71-E83.
6
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.在大流行期间治疗新冠病毒病——超说明书用药、同情用药及随机临床试验
JAMA. 2020 May 19;323(19):1897-1898. doi: 10.1001/jama.2020.4742.
7
Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions.民事诉讼能否遏制未经证实的干细胞干预措施面向消费者的直接营销浪潮？
NPJ Regen Med. 2018 Feb 19;3:5. doi: 10.1038/s41536-018-0043-6. eCollection 2018.
8
Marketing of unproven stem cell-based interventions: A call to action.未经证实的基于干细胞的干预措施的营销：行动呼吁。
Sci Transl Med. 2017 Jul 5;9(397). doi: 10.1126/scitranslmed.aag0426.
9
Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry.在美国销售干细胞：评估直接面向消费者的行业。
Cell Stem Cell. 2016 Aug 4;19(2):154-157. doi: 10.1016/j.stem.2016.06.007. Epub 2016 Jun 30.
10
SCIENTIFIC COMMUNITY. Confronting stem cell hype.科学界。直面干细胞炒作。
Science. 2016 May 13;352(6287):776-7. doi: 10.1126/science.aaf4620. Epub 2016 May 12.